After-Hours Movers

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 64.7% LOWER; announced today that the Company has decided to stop enrollment in the Phase 3 RECOVERY study of Tonmya# or TNX-102 SL* (cyclobenzaprine HCl sublingual tablets) 5.6 mg for the treatment of posttraumatic stress disorder (PTSD) following an unblinded, pre-specified interim analysis by the Independent Data Monitoring Committee (IDMC). Based on interim analysis results of the first 50% of enrolled participants, the IDMC recommended stopping the trial for futility as Tonmya is unlikely to demonstrate a statistically significant improvement in the primary endpoint of overall change from baseline in the severity of PTSD symptoms, as measured by the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) between those treated with Tonmya and those receiving placebo. Preliminary blinded safety data from these participants did not reveal any serious and/or unexpected adverse events and the decision to discontinue enrolling in the study is not related to safety. The Company intends to continue studying those participants currently enrolled until completion and then proceed with a full analysis of the unblinded data to determine the next steps in this program, with the topline results expected to be reported in the second quarter of 2020. The Company is reallocating resources from the PTSD program to the Phase 3 fibromyalgia study of TNX-102 SL 5.6 mg that is currently enrolling and from which interim results are expected in the third quarter.

Funko, Inc. (Nasdaq: FNKO) 35.8% LOWER; Net sales are expected to be approximately $214 million, a decrease of 8% compared to $233 million in the fourth quarter of 2018. Net sales were below expectations in mature markets, including the U.S., due to the challenging retail environment, which resulted in lower than expected purchases among Funkos top customers throughout the holiday season as well as softness in sales related to certain tentpole movie releases. These factors more than offset strong growth both in Europe and the Loungefly brand during the quarter. (*Consensus sees Q4 revenue of $264.3).

GoPro (NASDAQ: GPRO) 13.5% HIGHER; reported Q4 EPS of $0.70, $0.09 worse than the analyst estimate of $0.79. Revenue for the quarter came in at $528 million versus the consensus estimate of $565.95 million. GoPro sees FY2020 EPS of $0.40-$0.50, versus the consensus of $0.45.

EnerSys (NYSE: ENS) 12.9% HIGHER; reported Q3 EPS of $1.04, $0.09 worse than the analyst estimate of $1.13. Revenue for the quarter came in at $763.7 million versus the consensus estimate of $785.75 million.

ANGI Homeservices (NASDAQ: ANGI) 12.9% LOWER; reported Q4 EPS of $0.00, in-line with the analyst estimate of $0.00. Revenue for the quarter came in at $321.4 million versus the consensus estimate of $324.93 million. Adjusted EBITDA $200-$250

Ceridian (NYSE: CDAY) 11.8% LOWER; reported Q4 EPS of $0.08, $0.03 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $221.8 million versus the consensus estimate of $221.21 million. Ceridian sees FY2020 revenue of $903-908 million, versus the consensus of $929.8 million. Ceridian sees Q1 2020 revenue of $221-223 million, versus the consensus of $226.97 million.

Applied Genetic Technologies Corporation (Nasdaq: AGTC) 10.8% LOWER; announced that it has commenced an underwritten public offering of 6,000,000 shares of its common stock. All the shares in the offering will be sold by AGTC. In addition, AGTC expects to grant the underwriters a 30-day option to purchase up to an additional 900,000 shares of its common stock sold in the public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.

Sonos (NASDAQ: SONO) 10.3% HIGHER; reported Q1 EPS of $0.60, $0.12 better than the analyst estimate of $0.48. Revenue for the quarter came in at $562.1 million versus the consensus estimate of $545.49 million.

e.l.f. Beauty, Inc. (NYSE: ELF) 9.3% HIGHER; reported Q3 EPS of $0.24, $0.09 better than the analyst estimate of $0.15. Revenue for the quarter came in at $80.8 million versus the consensus estimate of $76.69 million. e.l.f. Beauty, Inc. sees FY2020 EPS of $0.55-$0.59, versus the consensus of $0.48. e.l.f. Beauty, Inc. sees FY2020 revenue of $274-277 million, versus the consensus of $271.62 million.

Peloton (NASDAQ: PTON) 8.3% LOWER; reported Q2 EPS of ($0.20), $0.16 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $466.3 million versus the consensus estimate of $422.93 million. Connected Fitness Subscribers grew 96% to 712,005; total Members grew to over 2.0 million. Peloton sees Q3 2020 revenue of $470-480 million, versus the consensus of $494.3 million.

FireEye (NASDAQ: FEYE) 5% LOWER; reported Q4 EPS of $0.07, $0.03 better than the analyst estimate of $0.04. Revenue for the quarter came in at $235 million versus the consensus estimate of $226.61 million. FireEye sees Q1 2020 EPS of $0.03-$0.05, versus the consensus of ($0.03). FireEye sees Q1 2020 revenue of $222-226 million, versus the consensus of $222.7 million.

Zynga (NASDAQ: ZNGA) 4.7% HIGHER; reported Q4 EPS of $0.00, $0.06 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $404 million versus the consensus estimate of $418.56 million. Zynga sees Q1 2020 EPS of ($0.03), versus the consensus of $0.06. Zynga sees Q1 2020 revenue of $385 million, versus the consensus of $411.98 million. Zynga sees FY2020 EPS of ($0.14), versus the consensus of $0.27. Zynga sees FY2020 revenue of $1.6 million, versus the consensus of $1.55 million.

FormFactor (NASDAQ: FORM) 4.3% HIGHER; reported Q4 EPS of $0.41, $0.10 better than the analyst estimate of $0.31. Revenue for the quarter came in at $178.6 million versus the consensus estimate of $173.99 million. FormFactor sees Q1 2020 EPS of $0.27-$0.35, versus the consensus of $0.28. FormFactor sees Q1 2020 revenue of $160-172 million, versus the consensus of $156.75 million.

Coherent, Inc. (NASDAQ: COHR) 3.7% HIGHER; reported Q1 EPS of $0.86, $0.09 better than the analyst estimate of $0.77. Revenue for the quarter came in at $320.8 million versus the consensus estimate of $318.23 million.

Nuance Communications (NASDAQ: NUAN) 2.7% HIGHER; reported Q1 EPS of $0.27, $0.04 better than the analyst estimate of $0.23. Revenue for the quarter came in at $418.3 million versus the consensus estimate of $406.64 million.